Chitosan derivatives as effective nanocarriers for ocular release of timolol drug

International Journal of Pharmaceutics

Volumn 495, Issue 1, 2015, Pages 249-264

  Siafaka, Panoraia I ^a   Titopoulou, Alexandra ^a   Koukaras, Emmanuel N ^b   Kostoglou, Margaritis ^a   Koutris, Efthimios ^c   Karavas, Evangelos ^c   Bikiaris, Dimitrios N ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c Pharmaceutical Industry   (Greece)

Author keywords

Chitosan derivatives; Nanoparticles; Ocular release; Timolol drug

Indexed keywords

2 CARBOXYBENZALDEHYDE; BENZALDEHYDE DERIVATIVE; CHITOSAN DERIVATIVE; NANOCARRIER; NANOPARTICLE; SUCCINIC ANHYDRIDE; TIMOLOL MALEATE; TRIPOLYPHOSPHATE; UNCLASSIFIED DRUG; CHITOSAN; DRUG CARRIER; POLYPHOSPHATE; TIMOLOL; TRIPHOSPHORIC ACID;

ARTICLE; DENSITY FUNCTIONAL THEORY; DRUG FORMULATION; DRUG RELEASE; GELATION; INFRARED SPECTROSCOPY; NANOENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; CHEMISTRY; EYE; MEDICINAL CHEMISTRY; PROCEDURES; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DRUG CARRIERS; DRUG LIBERATION; EYE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; POLYPHOSPHATES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SUCCINIC ANHYDRIDES; TIMOLOL; X-RAY DIFFRACTION;

EID: 84941335387     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.08.100     Document Type: Article

References (86)

1. Y. Aktas, K. Andrieux, M.J. Alonso, P. Calvo, R.N. Gursoy, and P. Couvreur Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor Int. J. Pharm. 298 2005 273 386
2. M.J. Alonso, and A. Sánchez The potential of chitosan in ocular drug delivery J. Pharm. Pharmacol. 55 2003 1451 1463
3. C. Androulidakis, E.N. Koukaras, O. Frank, G. Tsoukleri, D. Sfyris, J. Parthenios, N. Pugno, K. Papagelis, K.S. Novoselov, and C. Galiotis Failure processes in embedded monolayer graphene under axial compression Sci. Rep. 4 2014 5271 5279
4. R. Asasutjarit, T. Theerachayanan, P. Kewsuwan, S. Veeranodha, A. Fuongfuchat, and G. Ritthidej Development and evaluation of diclofenac sodium loaded-N-trimethyl chitosan nanoparticles for ophthalmic use AAPS PharmSciTech 2015 (in press)
5. E. Başaran, and Y. Yazan Ocular application of chitosan Expert Opin. Drug Deliv. 9 2012 701 712
6. J. Beukenkamp, W. Rieman, and S. Lindenbaum Behavior of condensed phosphates in anion-exchange chromatography Anal. Chem. 26 1954 505 512
7. R.S. Bhatta, H. Chandasana, Y.S. Chhonker, C. Rathi, D. Kumar, K. Mitra, and P.K. Shukla Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studies Int. J. Pharm. 432 2012 105 112
8. Y. Boonsongrit, A. Mitrevej, and B.W. Mueller Chitosan drug binding by ionic interaction Eur. J. Pharm. Biopharm. 62 2006 267 274
9. S.F. Boys, and F. Bernardi The calculation of small molecular interactions by the differences of separate total energies. Some procedures with reduced errors Mol. Phys. 19 1970 553 566
10. L. Calderón, R. Harris, M. Cordoba-Diaz, M. Elorza, B. Elorza, J. Lenoir, E. Adriaens, J.P. Remon, A. Heras, and D. Cordoba-Diaz Nano and microparticulate chitosan-based systems for antiviral topical delivery Eur. J. Pharm. Sci. 48 2013 216 222
11. P. Calvo, J.L. Vila-Jato, and M.J. Alonso Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers Int. J. Pharm. 153 1997 41 50
12. H.S. Choi, S. Seo, G. Khang, J.M. Rhee, and H.B. Lee Preparation and characterization of fentanyl-loaded PLGA microspheres: in vitro release profiles Int. J. Pharm. 234 2002 195 203
13. K. Cholkar, H.M. Trinh, D. Pal, and A.K. Mitra Discovery of novel inhibitors for the treatment of glaucoma Expert Opin. Drug Discov. 10 2015 1 21
14. Y.B. Choy, J.H. Park, and M.R. Prausnitz Mucoadhesive microparticles engineered for ophthalmic drug delivery J. Phys. Chem. Solids 69 2008 1533 1536
15. J. Crank The Mathematics of Diffusion 1967 Oxford University Press Oxford
16. A.M. De Campos, Y. Diebold, E.L. Carvalho, A. Sanchez, and M.J. Alonso Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity Pharm. Res. 21 2004 803 810
17. A.E. De Salamanca, Y. Diebold, M. Calonge, C. Garcia-Vazquez, S. Callejo, A. Vila, and M.J. Alonso Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance Investig. Ophthalmol. Vis. Sci. 47 2006 1416 1425
18. R.B. Desireddy, T.L. Kumari, C.N. Sowjanya, G. Sowjanya, and T.L.L. Reddy Ocular drug delivery system - emerging trends Int. J. Pharm. Sci. Rev. Res. 16 2012 29 33
19. A. Dubey, and P. Prabhu Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma Int. J. Pharm. Investig. 4 2014 112 118
20. S. El-Sousi, A. Nácher, C. Mura, A. Catalán-Latorre, V. Merino, M. Merino-Sanjuán, and O. Díez-Sales Hydroxypropylmethylcellulose films for the ophthalmic delivery of diclofenac sodium J. Pharm. Pharmacol. 65 2013 193 200
21. J.F. Fangueiro, T. Andreani, M.A. Egea, M.L. Garcia, S.B. Souto, A.M. Silva, and E.B. Souto Design of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicity Int. J. Pharm. 461 2014 64 73
22. O. Felt, P. Furrer, J.M. Mayer, B. Plazzonet, P. Bun, and R. Gurny Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention Int. J. Pharm. 180 1999 185 193
23. M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, and J.R. Cheeseman Gaussian 09, C.01 2009 Gaussian, Inc. Wallingford, CT, USA
24. G.O. Fulgêncio, F.A.B. Viana, R.R. Ribeiro, M.I. Yoshida, A.G. Faraco, and A.S. Cunha-Júnior New mucoadhesive chitosan film for ophthalmic drug delivery of timolol maleate: in vivo evaluation J. Ocul. Pharmacol. Ther. 28 2012 350 358
25. I. Galdi, and G. Lamberti Drug release from matrix system analysis by finite element methods Heat Mass Transf. 48 2012 519 528
26. S. Grimme GGA-type density functional constructed with a long-range dispersion correction J. Comput. Chem. 27 2006 1787 1799
27. K. Hermans, D. Van den Plas, S. Kerimova, R. Carleer, P. Adriaensens, W. Weyenberg, and A. Ludwig Development and characterization of mucoadhesive chitosan films for ophthalmic delivery of cyclosporine Int. J. Pharm. 472 2014 10 19
28. W.I. Higuchi Diffusional models useful in biopharmaceutics drug release rate processes J. Pharm. Sci. 56 1967 314 324
29. S. Hirano, and T. Moriyasu N-(Carboxyacyl)chitosans Carbohydr. Res. 92 1981 323 327
30. H.W. Hui, and J.R. Robinson Ocular delivery of progesterone using a bioadhesive polymer Int. J. Pharm. 26 1985 203 213
31. H.J. Jung, M. Abou-Jaoude, B.E. Carbia, C. Plummer, and A. Chauhan Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses J. Control. Release 165 2013 82 89
32. E. Karavas, M. Georgarakis, A. Docoslis, and D. Bikiaris Combining SEM, TEM, and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly-water soluble drug within a polymer matrix Int. J. Pharm. 340 2007 76 83
33. Y. Kato, H. Onishi, and Y. Machida N-Succinyl-chitosan as a drug carrier: water-insoluble and water-soluble conjugates Biomaterials 25 2004 907 915
34. R.W. Korsmeyer, R. Gurny, E. Doelker, P. Buri, and N.A. Peppas Mechanisms of solute release from porous hydrophilic polymers Int. J. Pharm. 15 1983 25 35
35. E.N. Koukaras, S.A. Papadimitriou, D.N. Bikiaris, and G.E. Froudakis Insight on the formation of chitosan nanoparticles through ionotropic gelation with tripolyphosphate Mol. Pharm. 9 2012 2856 2862
36. E.N. Koukaras, S.A. Papadimitriou, D.N. Bikiaris, and G.E. Froudakis Properties and energetics for design and characterization of chitosan nanoparticles used for drug encapsulation RSC Adv. 4 2014 12653 12661
37. K.P. Koutroumanis, K. Avgoustakis, and D. Bikiaris Synthesis of cross-linked N-(2-carboxybenzyl)chitosan pH sensitive polyelectrolyte and its use for drug controlled delivery Carbohydr. Polym. 82 2010 181 188
38. G.Z. Kyzas, P.I. Siafaka, E.G. Pavlidou, K.J. Chrissafis, and D.N. Bikiaris Synthesis and adsorption application of succinyl-grafted chitosan for the simultaneous removal of zinc and cationic dye from binary hazardous mixtures Chem. Eng. J. 259 2015 438 448
39. N.K. Lazaridis, G.Z. Kyzas, A.A. Vassiliou, and D.N. Bikiaris Chitosan derivatives as biosorbents for basic dyes Langmuir 23 2007 7634 7643
40. C. Le Tien, M. Lacroix, P. Ispas-Szabo, and M.A. Mateescu N-Acylated chitosan: hydrophobic matrices for controlled drug release J. Control. Release 93 2003 1 13
41. Y. Lin, Q. Chen, and H. Luo Preparation and characterization of N-(2-carboxybenzyl)chitosan as a potential pH-sensitive hydrogel for drug delivery Carbohydr. Res. 342 2007 87 94
42. S. Liu, L. Jones, and F.X. Gu Nanomaterials for ocular drug delivery Macromol. Biosci. 12 2012 608 620
43. A. Ludwig The use of mucoadhesive polymers in ocular drug delivery Adv. Drug Deliv. Rev. 57 2005 1595 1639
44. V. Mishra, and N.K. Jain Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits Int. J. Pharm. 461 2014 380 390
45. G. Mohammadi, A. Nokhodchi, M. Barzegar-Jalali, F. Lotfipour, K. Adibkia, N. Ehyaei, and H. Valizadeh Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system Colloids Surf. B: Biointerfaces 88 2011 39 44
46. C.A. Morgado, P. Jurecka, D. Svozil, P. Hobza, and J. Sponer Reference MP2/CBS and CCSD(T) quantum-chemical calculations on stacked adenine dimers. Comparison with DFT-D, MP2.5, SCS(MI)-MP2, M06-2X, CBS(SCS-D) and force field descriptions PCCP 12 2010 3522 3534
47. R.A.A. Muzzarelli, F. Tanfani, S. Marriotti, and M. Emanuelli N-(o-Carboxybenzyl)chitosans: novel chelating polyampholytes Carbohydr. Polym. 2 1982 145 157
48. R.C. Nagarwal, P.N. Singh, S. Kant, P. Maiti, and J.K. Pandit Chitosan nanoparticles of 5-fluorouracil for ophthalmic delivery: characterization, in-vitro and in-vivo study Chem. Pharm. Bull. 59 2011 272 278
49. R.C. Nagarwal, R. Kumar, and J.K. Pandit Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye Eur. J. Pharm. Sci. 47 2012 678 685
50. K. Nan, F. Ma, H. Hou, W.R. Freeman, M.J. Sailor, and L. Cheng Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin Acta Biomater. 10 2014 3505 3512
51. G.D. Novack Ophthalmic beta-blockers since timolol Surv. Opthalmol. 31 1987 307 327
52. P. Pahuja, S. Arora, and P. Pawar Ocular drug delivery system: a reference to natural polymers Expert Opin. Drug Deliv. 9 2012 837 861
53. Y. Pan, J.M. Zheng, H.Y. Zhao, Y.J. Li, H. Xu, and G. Wei Relationship between drug effects and particle sizeof insulin-loaded bioadhesive microspheres Acta Pharmacol. Sin. 23 2002 1051 1056
54. Y. Pan, Y.J. Li, H.Y. Zhao, J.M. Zheng, H. Xu, and G. Wei Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo Int. J. Pharm. 349 2007 139 147
55. S. Papadimitriou, D. Bikiaris, K. Avgoustakis, E. Karavas, and M. Georgarakis Chitosan nanoparticles loaded with dorzolamide and pramipexole Carbohydr. Polym. 73 2008 44 54
56. R. Peverati, and K. Baldridge Implementation and performance of DFT-D with respect to basis set and functional for study of dispersion interactions in nanoscalearomatic hydrocarbons J. Chem. Theory Comput. 4 2008 2030 2048
57. E. Pirona, and A. Domard Interaction between chitosan and uranyl ions. Part 2. Mechanism of interaction Int. J. Biol. Macromol. 22 1998 33 40
58. K.V. Harish Prashanth, F.S. Kittur, and R.N. Tharanathan Solid state structure of chitosan prepared under different N-deacetylating conditions Carbohydr. Polym. 50 2002 27 33
59. H.A. Quigley, and A.T. Broman The number of people with glaucoma worldwide in 2010 and 2020 Br. J. Ophthalmol. 90 2006 262 267
60. C. Raman, C. Berkland, K. Kim, and D.W. Pack Modeling small-molecule release from PLG microspheres: effects of polymer degradation and nonuniform drug distribution J. Control. Release 103 2005 149 158
61. G. Rassu, E. Gavini, H. Jonassen, Y. Zambito, S. Fogli, M.C. Breschi, and P. Giunchedi Derivatives for the preparation of rokitamycin loaded microspheres designed for ocular or nasal administration J. Pharm. Sci. 98 2009 4852 4865
62. K. Sabitha, C.I. Sajeeth, and K. Santh Chitosan nanoparticles: a novel vehicle for the enhanced ocular delivery of moxifloxacin HCl Res. J. Pharm. Biol. Chem. Sci. 3 2012 534 548
63. A. Schäfer, C. Huber, and R. Ahlrichs Fully optimized contracted Gaussian basis sets of triple zeta valence quality for atoms Li to Kr J. Chem. Phys. 100 1994 5829 5835
64. L. Servat-Medina, A. González-Gómez, F. Reyes-Ortega, I.M. Oliveira Sousa, N. de Cássia Almeida Queiroz, P.M. WiziackZago, M.P. Jorge, K.M. Monteiro, J.E. de Carvalho, J.S. Román, and M.A. Foglio Chitosan-tripolyphosphate nanoparticles as Arrabidaea chica standardized extract carrier: synthesis, characterization, biocompatibility, and antiulcerogenic activity Int. J. Nanomed. 10 2015 3897 3909
65. N.C. Silva, S. Silva, B. Sarmento, and M. Pintado Chitosan nanoparticles for daptomycin delivery in ocular treatment of bacterial endophthalmitis Drug Deliv. 2013 10.3109/10717544.2013.858195
66. U. Shinde, M.H. Ahmed, and K. Singh Development of dorzolamide loaded 6-O-carboxymethyl chitosan nanoparticles for open angle glaucoma J. Drug Deliv. 2013 2013 1 15
67. K.H. Singh, and U.A. Shinde Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane Pharmazie 66 2011 594 599
68. G. Singhvi, and M. Singh Review: in-vitro drug release characterization models Int. J. Pharm. Stud. Res. 2 2011 77 84
69. T.A. Sonia, and C.P. Sharma Chitosan and its derivatives for drug delivery perspective Adv. Polym. Sci. 243 2011 23 54
70. A. Sosnik, J. das Neve, and B. Sarmento Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review Prog. Polym. Sci. 39 2014 2030 2075
71. T. Stukenkemper, A. Dose, M.C. Gonzalez, A.J.J. Groenen, S. Hehir, V. Andrés-Guerrero, R.H. Vanrell, and N.R. Cameron Block copolypeptide nanoparticles for the delivery of ocular therapeutics Macromol. Biosci. 24 2014 138 145
72. P. Sun, P. Li, Y.M. Li, Q. Wei, and L.H. Tian A pH-sensitive chitosan-tripolyphosphate hydrogel beads for controlled glipizide delivery J. Biomed. Mater. Res. Part B 97 2011 175 183
73. B. Tian, Q. Luo, S.S. Song, D. Liu, H. Pan, W. Zhang, L. He, S. Ma, X. Yang, and W. Pan Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery J. Pharm. Sci. 101 2012 1040 1049
74. C. Tien Adsorption Calculations and Modeling 1994 Butterworth-Heinemann Boston, USA
75. N. Üstündaʇ-Okur, E. Homan Gökçe, D. İnciBozbIyIk, S. Eʇrilmez, Ö. Özer, and G. Ertan Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis Eur. J. Pharm. Sci. 63 2014 204 215
76. N. Üstündaʇ-Okur, E. Homan Gökçe, D.I. BozbIyIk, S. Eʇrilmez, G. Ertan, and Ö. Özer Novel nanostructured lipid carrier-based inserts forcontrolled ocular drug delivery: evaluation of cornealbioavailability and treatment efficacy in bacterialkeratitis Expert Opin. Drug Deliv. 12 2015 1 17
77. A. Vyas, and S. Saraf Encapsulation of cyclodextrincomplexed simvastatin in chitosan nanocarriers: a novel technique for oral delivery J. Incl. Phenom. Macrocycl. Chem. 66 2010 251 259
78. J.P. Wang, Y.Z. Chen, S.J. Zhang, and H.Q. Yu A chitosan-based flocculant prepared with gamma-irradiation-induced grafting Bioresour. Technol. 99 2008 3397 3402
79. J.J. Wang, Z.W. Zeng, R.Z. Xiao, T. Xie, G.L. Zhou, X.R. Zhan, and S.L. Wang Recent advances of chitosan nanoparticles as drug carriers Int. J. Nanomed. 6 2011 765 774
80. A. Zafar, J. Ali, A. Bhatnagar, N.J. Kumar, and A. Ali Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits Int. J. Biol. Macromol. 65 2014 479 491
81. H. Zhang, M. Oh, C. Allen, and E. Kumacheva Monodisperse chitosan nanoparticles for mucosal drug delivery Biomacromolecules 5 2004 2461 2468
82. Y. Zhou, and X.Y. Wu Finite element analysis of diffusional drug release from complex matrix systems I. Complex geometries and composite structures J. Control. Release 49 1997 277 288
83. B.W. Zhou, Y. Wang, J. Jian, and S. Song Self-aggregated nanoparticles based on amphiphilicpoly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B Int. J. Nanomed. 8 2013 3715 3728
84. H.Y. Zhou, J.L. Hao, S. Wang, Y. Zheng, and W.S. Zhang Nanoparticle sin ocular drug delivery Int. J. Opthalmol. 6 2013 390 396
85. A.K. Zimmer, and J. Kreuter Microspheres and nanoparticles used in ocular delivery systems Adv. Drug Deliv. Rev. 16 1995 61 73
86. A.K. Zimmer, H. Zerbe, and J. Kreuter Evaluation of pilocarpine loaded albumin particles as drug delivery systems for controlled delivery in the eye. In vitro and in vivo characterization J. Control. Release 32 1994 57 70